{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:34:08Z","timestamp":1788240848012,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03659-8","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T23:33:00Z","timestamp":1736897580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Observation on the efficacy of TPO receptor agonists and platelet transfusion in chemotherapy-induced thrombocytopenia in malignant tumors"],"prefix":"10.1186","volume":"23","author":[{"given":"Huan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"3659_CR1","doi-asserted-by":"publisher","unstructured":"Sahin TK, Rizzo A, Aksoy S, Guven DC. Prognostic significance of the Royal Marsden Hospital (RMH) score in patients with cancer: a systematic review and meta-analysis. Cancers (Basel). 2024;16(10):1835. Published 2024 May 11. https:\/\/doi.org\/10.3390\/cancers16101835","DOI":"10.3390\/cancers16101835"},{"issue":"12","key":"3659_CR2","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1080\/17425255.2021.2029405","volume":"17","author":"A Rizzo","year":"2021","unstructured":"Rizzo A, Santoni M, Mollica V, et al. Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 study. Expert Opin Drug Metab Toxicol. 2021;17(12):1455\u201366. https:\/\/doi.org\/10.1080\/17425255.2021.2029405","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3659_CR3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.thromres.2022.11.024","volume":"231","author":"EC Josefsson","year":"2023","unstructured":"Josefsson EC. Platelet intrinsic apoptosis. Thromb Res. 2023;231:206\u201313. https:\/\/doi.org\/10.1016\/j.thromres.2022.11.024. Epub 2022 Dec 12. PMID.","journal-title":"Thromb Res"},{"issue":"2","key":"3659_CR4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1161\/CIRCRESAHA.121.319821","volume":"130","author":"M Koupenova","year":"2022","unstructured":"Koupenova M, Livada AC, Morrell CN. Platelet and megakaryocyte roles in innate and adaptive immunity. Circ Res. 2022;130(2):288\u2013308. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.319821. Epub 2022 Jan 20. PMID: 35050690; PMCID: PMC8852355.","journal-title":"Circ Res"},{"issue":"4","key":"3659_CR5","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3324\/haematol.2020.251900","volume":"106","author":"H Al-Samkari","year":"2021","unstructured":"Al-Samkari H, Parnes AD, Goodarzi K, Weitzman JI, Connors JM, Kuter DJ. A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies. Haematologica. 2021;106(4):1148\u201357. https:\/\/doi.org\/10.3324\/haematol.2020.251900. PMID: 32499239; PMCID: PMC8018116.","journal-title":"Haematologica"},{"issue":"1","key":"3659_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40360-023-00707-5","volume":"24","author":"W Chen","year":"2023","unstructured":"Chen W, Liu Y, Li L, Zeng X. Efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a meta-analysis. BMC Pharmacol Toxicol. 2023;24(1):71. https:\/\/doi.org\/10.1186\/s40360-023-00707-5. PMID: 38041150; PMCID: PMC10693054.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"5","key":"3659_CR7","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/ejh.13595","volume":"106","author":"JL Shaw","year":"2021","unstructured":"Shaw JL, Nielson CM, Park JK, Marongiu A, Soff GA. The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies. Eur J Haematol. 2021;106(5):662\u201372. https:\/\/doi.org\/10.1111\/ejh.13595. Epub 2021 Feb 16. PMID: 33544940; PMCID: PMC8248430.","journal-title":"Eur J Haematol"},{"issue":"12","key":"3659_CR8","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1111\/jth.13511","volume":"14","author":"R Teng","year":"2016","unstructured":"Teng R, Carlson GF, Nylander S, Andersson TL. Effects of autologous platelet transfusion on platelet inhibition in ticagrelor-treated and clopidogrel-treated subjects. J Thromb Haemost. 2016;14(12):2342\u201352. https:\/\/doi.org\/10.1111\/jth.13511. Epub 2016 Oct 31. PMID: 27653814.","journal-title":"J Thromb Haemost"},{"issue":"12","key":"3659_CR9","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1111\/trf.17157","volume":"62","author":"FLF van Baarle","year":"2022","unstructured":"van Baarle FLF, de Bruin S, Bulle EB, van Mourik N, Lim EHT, Tuip-de Boer AM, Bongers A, de Wissel MB, van Bruggen R, de Korte D, Vermeulen C, Tan KW, Jonkers RE, Bonta PI, Lutter R, Dekker T, Dierdorp BS, Peters AL, Biemond BJ, Vlaar APJ. Aged versus fresh autologous platelet transfusion in a two-hit healthy volunteer model of transfusion-related acute lung injury. Transfusion. 2022;62(12):2490\u2013501. https:\/\/doi.org\/10.1111\/trf.17157. Epub 2022 Oct 27. PMID: 36300793; PMCID: PMC10092071.","journal-title":"Transfusion"},{"issue":"3","key":"3659_CR10","doi-asserted-by":"publisher","first-page":"711","DOI":"10.19746\/j.cnki.issn.1009-2137.2022.03.008","volume":"30","author":"JF Dai","year":"2022","unstructured":"Dai JF, Xia RX. Effect of rhTPO and rhIL-11 on thrombocytopenia after chemotherapy in leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022;30(3):711\u20137. https:\/\/doi.org\/10.19746\/j.cnki.issn.1009-2137.2022.03.008. Chinese. PMID: 35680794.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"6","key":"3659_CR11","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3324\/haematol.2018.212845","volume":"104","author":"W Ghanima","year":"2019","unstructured":"Ghanima W, Cooper N, Rodeghiero F, Godeau B, Bussel JB. Thrombopoietin receptor agonists: ten years later. Haematologica. 2019;104(6):1112\u201323. https:\/\/doi.org\/10.3324\/haematol.2018.212845. Epub 2019 May 9. PMID: 31073079; PMCID: PMC6545830.","journal-title":"Haematologica"},{"key":"3659_CR12","unstructured":"Drugs. and Lactation Database (LactMed\u00ae). Bethesda (MD): National Institute of Child Health and Human Development; 2006\u2013. Eltrombopag. 2023 Mar 15. PMID: 34813256."},{"issue":"7","key":"3659_CR13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41419-023-05918-6","volume":"14","author":"M Chen","year":"2023","unstructured":"Chen M, Hu L, Bao X, Ye K, Li Y, Zhang Z, Kaufmann SH, Xiao J, Dai H. Eltrombopag directly activates BAK and induces apoptosis. Cell Death Dis. 2023;14(7):394. https:\/\/doi.org\/10.1038\/s41419-023-05918-6. PMID: 37393297; PMCID: PMC10314921.","journal-title":"Cell Death Dis"},{"key":"3659_CR14","doi-asserted-by":"publisher","first-page":"100909","DOI":"10.1016\/j.blre.2021.100909","volume":"53","author":"DJ Kuter","year":"2022","unstructured":"Kuter DJ. The structure, function, and clinical use of the thrombopoietin receptor agonist avatrombopag. Blood Rev. 2022;53:100909. https:\/\/doi.org\/10.1016\/j.blre.2021.100909. Epub 2021 Nov 16. PMID: 34815110.","journal-title":"Blood Rev"},{"key":"3659_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/TCRM.S251672","volume":"18","author":"G Tsykunova","year":"2022","unstructured":"Tsykunova G, Ghanima W. Avatrombopag for the treatment of adult patients with chronic immune thrombocytopenia (cITP): focus on patient selection and perspectives. Ther Clin Risk Manag. 2022;18:273\u201386. https:\/\/doi.org\/10.2147\/TCRM.S251672. PMID: 35386180; PMCID: PMC8977771.","journal-title":"Ther Clin Risk Manag"},{"issue":"31","key":"3659_CR16","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1200\/JCO.18.01931","volume":"37","author":"GA Soff","year":"2019","unstructured":"Soff GA, Miao Y, Bendheim G, Batista J, Mones JV, Parameswaran R, Wilkins CR, Devlin SM, Abou-Alfa GK, Cercek A, Kemeny NE, Sarasohn DM, Mantha S. Romiplostim treatment of chemotherapy-induced thrombocytopenia. J Clin Oncol. 2019;37(31):2892\u20138. Epub 2019 Sep 23. PMID: 31545663; PMCID: PMC6823892.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3659_CR17","first-page":"188","volume":"51","author":"GQ Liu","year":"2012","unstructured":"Liu GQ, Ding HF, Lu XJ, Xu M, Xing J, Zhao X, Han F, Shang YH. The efficacy and safety of autologous cryopreserved platelet transfusion in management of thrombocytopenia after chemotherapy in hematological malignancy. Zhonghua Nei Ke Za Zhi. 2012;51(3):188\u201391. Chinese. PMID: 22781890.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"40","key":"3659_CR18","doi-asserted-by":"publisher","first-page":"e35353","DOI":"10.1097\/MD.0000000000035353","volume":"102","author":"H Yu","year":"2023","unstructured":"Yu H, Chen R, Zhou Z, Liu R, Wen J. Efficacy and safety of caffeic acid tablets in the treatment of thrombocytopenia: a systematic review and meta-analysis. Med (Baltim). 2023;102(40):e35353. https:\/\/doi.org\/10.1097\/MD.0000000000035353. PMID: 37800784; PMCID: PMC10553084.","journal-title":"Med (Baltim)"},{"issue":"7","key":"3659_CR19","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1080\/09537104.2022.2026910","volume":"33","author":"Y Gao","year":"2022","unstructured":"Gao Y, Liu Q, Shen Y, Li Y, Shao K, Ye B, Shen Y, Zhou Y, Wu D. Effect of avatrombopag in the management of severe and refractory chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors. Platelets. 2022;33(7):1024\u201330. Epub 2022 Jan 18. PMID: 35040375.","journal-title":"Platelets"},{"issue":"24","key":"3659_CR20","doi-asserted-by":"publisher","first-page":"4718","DOI":"10.7150\/jca.26690","volume":"9","author":"Y Xu","year":"2018","unstructured":"Xu Y, Song X, Du F, Zhao Q, Liu L, Ma Z, Lu S. A randomized controlled study of rhTPO and rhIL-11 for the prophylactic treatment of chemotherapy-induced thrombocytopenia in non-small cell lung cancer. J Cancer. 2018;9(24):4718\u201325. https:\/\/doi.org\/10.7150\/jca.26690. PMID: 30588257; PMCID: PMC6299384.","journal-title":"J Cancer"},{"key":"3659_CR21","doi-asserted-by":"publisher","unstructured":"Society of Chemotherapy, China Anti-Cancer Association; Committee of Neoplastic Supportive-Care, China Anti-Cancer Association. Consensus on the clinical diagnosis, treatment and prevention of cancer treatment-induced thrombocytopenia in China (2023 edition). Zhonghua Yi Xue Za Zhi. 2023;103(33):2579\u20132590. Chinese. https:\/\/doi.org\/10.3760\/cma.j.cn112137-20230409-00575. PMID: 37650204.","DOI":"10.3760\/cma.j.cn112137-20230409-00575"},{"key":"3659_CR22","doi-asserted-by":"publisher","unstructured":"Consensus Committee of Chemotherapy Induced Thrombocytopenia, Chinese Society of Clinical Oncology. Consensus on clinical diagnosis, treatment and prevention management of chemotherapy induced thrombocytopenia in China(2018). Zhonghua Zhong Liu Za Zhi. 2018;40(9):714\u2013720. Chinese. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-3766.2018.09.014. PMID: 30293399.","DOI":"10.3760\/cma.j.issn.0253-3766.2018.09.014"},{"key":"3659_CR23","doi-asserted-by":"publisher","unstructured":"Xiao Y, Liu J, Huang XE, Guo JX, Fu PC, Huang XH, Zhou J, Ye AQ. A clinical study on Juheli (Recombinant human interleukin \u2013\u200911) in the second prevention of chemotherapy induced thrombocytopenia. Asian Pac J Cancer Prev. 2016;17(2):485-9. https:\/\/doi.org\/10.7314\/apjcp.2016.17.2.485. PMID: 26925632.","DOI":"10.7314\/apjcp.2016.17.2.485"},{"issue":"6","key":"3659_CR24","doi-asserted-by":"publisher","first-page":"e0257673","DOI":"10.1371\/journal.pone.0257673","volume":"17","author":"GA Soff","year":"2022","unstructured":"Soff GA, Ray-Coquard I, Rivera LJM, Fryzek J, Mullins M, Bylsma LC, Park JK. Systematic literature review and meta-analysis on use of thrombopoietic agents for chemotherapy-induced thrombocytopenia. PLoS ONE. 2022;17(6):e0257673. https:\/\/doi.org\/10.1371\/journal.pone.0257673. PMID: 35679540; PMCID: PMC9183450.","journal-title":"PLoS ONE"},{"issue":"2","key":"3659_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1053\/j.seminhematol.2019.10.001","volume":"57","author":"CF Prodger","year":"2020","unstructured":"Prodger CF, Rampotas A, Estcourt LJ, Stanworth SJ, Murphy MF. Platelet transfusion: alloimmunization and refractoriness. Semin Hematol. 2020;57(2):92\u20139. https:\/\/doi.org\/10.1053\/j.seminhematol.2019.10.001. Epub 2019 Nov 8. PMID: 32892848.","journal-title":"Semin Hematol"},{"issue":"1","key":"3659_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41409-021-01482-9","volume":"57","author":"C Savoia","year":"2022","unstructured":"Savoia C, McKeough N, Hickey B, Cochrane T. Comparison of a therapeutic platelet transfusion strategy to a prophylactic platelet transfusion strategy in autologous stem cell transplant (ASCT), a single centre experience. Bone Marrow Transpl. 2022;57(1):122\u20134. https:\/\/doi.org\/10.1038\/s41409-021-01482-9. Epub 2021 Oct 6. PMID: 34616006.","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"3659_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ajh.27080","volume":"99","author":"ZM Virk","year":"2024","unstructured":"Virk ZM, Leaf RK, Kuter DJ, Goodarzi K, Connell NT, Connors JM, Al-Samkari H. Avatrombopag for adults with early versus chronic immune thrombocytopenia. Am J Hematol. 2024;99(2):155\u201362. https:\/\/doi.org\/10.1002\/ajh.27080. Epub 2023 Dec 8. PMID: 38063420.","journal-title":"Am J Hematol"},{"key":"3659_CR28","doi-asserted-by":"publisher","unstructured":"Jain S, Gernsheimer T, Kolodny S, Bernheisel C, Vredenburg M, Panch SR. Additional efficacy analysis of avatrombopag phase III data for the treatment of adults with immune thrombocytopenia. Platelets. 2023;34(1):2195016. https:\/\/doi.org\/10.1080\/09537104.2023.2195016. PMID: 37013676.","DOI":"10.1080\/09537104.2023.2195016"},{"key":"3659_CR29","doi-asserted-by":"publisher","first-page":"204062072412376","DOI":"10.1177\/20406207241237606","volume":"15","author":"Y Qin","year":"2024","unstructured":"Qin Y, Wang Y, Zhang Y, Jiao Y, Ye J. Avatrombopag for the salvage treatment of platelet transfusion refractoriness. Ther Adv Hematol. 2024;15:20406207241237606. https:\/\/doi.org\/10.1177\/20406207241237606. PMID: 38481948; PMCID: PMC10935753.","journal-title":"Ther Adv Hematol"},{"key":"3659_CR30","doi-asserted-by":"publisher","first-page":"e927008","DOI":"10.12659\/AJCR.927008","volume":"21","author":"N Gabrail","year":"2020","unstructured":"Gabrail N, Smith C. Avatrombopag optimizes response to niraparib by managing thrombocytopenia associated with poly-ADP ribose polymerase (PARP) inhibition in ovarian cancer and breast cancer: a case series. Am J Case Rep. 2020;21:e927008. https:\/\/doi.org\/10.12659\/AJCR.927008. PMID: 33191394; PMCID: PMC7682497.","journal-title":"Am J Case Rep"},{"key":"3659_CR31","doi-asserted-by":"publisher","first-page":"175628482211059","DOI":"10.1177\/17562848221105976","volume":"15","author":"J Lu","year":"2022","unstructured":"Lu J, Jamieson BD, Hui AM. Avatrombopag ethnic sensitivity analysis in chronic liver disease and thrombocytopenia patients: individual-level pooled analysis. Th Adv Gastroenterol. 2022;15:17562848221105976. https:\/\/doi.org\/10.1177\/17562848221105976. PMID: 35795378; PMCID: PMC9252017.","journal-title":"Th Adv Gastroenterol"},{"issue":"5","key":"3659_CR32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/MBC.0000000000001232","volume":"34","author":"W Lebowa","year":"2023","unstructured":"Lebowa W, Zdziarska J, Sacha T. Avatrombopag increased platelet count in a patient with chronic immune thrombocytopenia refractory to multiple lines of treatment. Blood Coagul Fibrinolysis. 2023;34(5):327\u201332. https:\/\/doi.org\/10.1097\/MBC.0000000000001232. Epub 2023 Jun 2. PMID: 37395226; PMCID: PMC10942213.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"3659_CR33","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3390\/hematolrep15030054","volume":"15","author":"M Abdelsamia","year":"2023","unstructured":"Abdelsamia M, Farid S, Dean S, Cataland SR. Thrombotic complications in immune thrombocytopenia patients treated with avatrombopag. Hematol Rep. 2023;15(3):518\u201323. https:\/\/doi.org\/10.3390\/hematolrep15030054. PMID: 37754669; PMCID: PMC10531320.","journal-title":"Hematol Rep"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03659-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03659-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03659-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T23:33:05Z","timestamp":1736897585000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03659-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3659"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03659-8","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not involve any special intervention or handling of sensitive information, and therefore did not require ethical review. Chongqing University Cancer Hospital has agreed to exemption from review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}